Atea Pharmaceuticals (AVIR) Return on Capital Employed [ROCE] (2020 - 2026)
Atea Pharmaceuticals' Return on Capital Employed [ROCE] was -82.87% in Q2 2026, down 43.29 percentage points from -39.58% a year earlier and down 9.22 percentage points from the prior quarter.
Powered by 
Analysis
Atea Pharmaceuticals (AVIR) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends
For FY2025, Return on Capital Employed [ROCE] at Atea Pharmaceuticals came in at -51.66%, down 13.92 percentage points from FY2024.
- Return on Capital Employed [ROCE] has now declined for four consecutive years, with a five-year change of -42.98 percentage points (FY2020 to FY2025).
- In earlier years, Return on Capital Employed [ROCE] was -37.74% in FY2024 (-10.31 pp), -27.43% in FY2023 (-8.80 pp), -18.63% in FY2022 (-36.80 pp) and 18.17% in FY2021 (+26.86 pp).
- The Q2 2026 figure marks the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q4 2020.
- Compared with a year earlier, Return on Capital Employed [ROCE] has declined for four straight quarters, with an average year-over-year change of -16.86 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q4 2021 (a gain of 24.87 percentage points); the worst was Q2 2026 (a drop of 43.29 percentage points).
- Per Business Quant data, AVIR's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -73.65% (Q1 2026), -62.52% (Q4 2025) and -47.53% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.32% |
| 10 | Atea Pharmaceuticals | 337.28 Mn | -631.22 Mn | - | -89.86% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -89.86% |
| Jun 30, 2026 | -82.87% |
| Mar 31, 2026 | -73.65% |
| Dec 31, 2025 | -62.52% |
| Sep 30, 2025 | -47.53% |
| Jun 30, 2025 | -39.58% |
| Mar 31, 2025 | -37.67% |
| Dec 31, 2024 | -42.02% |
| Sep 30, 2024 | -42.17% |
| Jun 30, 2024 | -40.40% |
| Mar 31, 2024 | -36.12% |
| Dec 31, 2023 | -28.84% |
| Sep 30, 2023 | -26.33% |
| Jun 30, 2023 | -21.59% |
| Mar 31, 2023 | -20.32% |
| Dec 31, 2022 | -19.85% |
| Sep 30, 2022 | 4.51% |
| Jun 30, 2022 | 3.61% |
| Mar 31, 2022 | 9.15% |
| Dec 31, 2021 | 18.42% |
API Access
Atea Pharmaceuticals Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=AVIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "AVIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=AVIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();